Medpace Holdings Raises FY2026 GAAP EPS Guidance from $17.25-$17.95 to $17.97-$18.32 vs $17.60 Est; Narrows FY2026 Sales Guidance from $2.805B-$2.885B to $2.835B-$2.855B vs $2.851B Est

Benzinga

2026.10.21 20:19 (GMT+0)

Benzingaで開く